ECG vs GVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

ECG

44.6
AI Score
VS
ECG Wins

GVA

34.8
AI Score

Investment Advisor Scores

ECG

45score
Recommendation
HOLD

GVA

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ECG GVA Winner
Revenue 3.65B 4.13B GVA
Net Income 234.12M -316.65M ECG
Gross Margin 14.2% 16.6% GVA
Net Margin 6.4% -7.7% ECG
Operating Income 311.86M 320.01M GVA
ROE 27.1% -33.5% ECG
ROA 8.7% -7.1% ECG
Total Assets 2.71B 4.47B GVA
Debt/Equity 0.66 1.64 ECG
Current Ratio 1.53 1.11 ECG

Relative Price Performance (Last 90 Days)

ECG 1M: -24.7% · 3M: -35.2% GVA 1M: +11.7% · 3M: +2.2%

Current Technical Phase

ECG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.3%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $89.11

GVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 59.9 · Price: $126.40

Fundamentals Snapshot

Metric ECG GVA
Market Cap — —
Forward P/E 12.7 14.9
Trailing P/E 14.9 —
Revenue (TTM) — —
Revenue Growth 0.4% 0.2%
Gross Margin 0.1% 0.2%
Operating Margin 0.1% 0.1%
EPS 5.74 -6.20
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.